One study compared laryngeal findings in MSA, SCA1, and SCA3 patients and found vocal fold paralysis to be less prevalent in SCA1 and SCA3 in comparison to MSA (in 29% in SCA1 and 16% in SCA3 in contrast to 82% in MSA) (39). The gene discussed is ATXN3; the disease is multiple system atrophy.